0
Other Articles |

Paul Ehrlich

JAMA. 1951;146(1):73-74. doi:10.1001/jama.1951.03670010077037.
Text Size: A A A
Published online

ABSTRACT

This biography is a sensitive and warmly personal account of the life of Paul Ehrlich, the discoverer of salvarsan (606). The author was Ehrlich's personal secretary from 1902 until his death in 1915 so that she is eminently qualified to record her firsthand observations of Ehrlich's daily work in his laboratory and at home. Where previously the man's scientific accomplishments have been recognized, his mental and spiritual greatness, his perpetual humility and his innate sympathy and kindliness toward his fellow man are now observed. The introduction by Sir Henry Dale confirms the subsequent story.

This is the story of Ehrlich's whole life, though it emphasizes the period during which the author worked for him. We learn of his early fascination with chemistry, his essential work in serum therapy, his development of "the side-chain theory," his growing preoccupation with chemotherapy and his discovery of salvarsan, which to him was only a

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs